title: Clinical outcome of long-term lamivudine treated chronic HBV infected and HIV/HBV coinfected patients.
authors.forename: Ioannis S
authors.initials: IS
authors.lastname: Elefsiniotis
authors.forename: V
authors.initials: V
authors.lastname: Paparizos
authors.forename: S P
authors.initials: SP
authors.lastname: Dourakis
authors.forename: C
authors.initials: C
authors.lastname: Mpotsi
authors.forename: K D
authors.initials: KD
authors.lastname: Pantazis
authors.forename: N
authors.initials: N
authors.lastname: Katsambas
mesh_terms: D000328:Adult; D019380:Anti-HIV Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005260:Female; D015658:HIV Infections / Q000150:complications / Q000188:drug therapy / Q000503:physiopathology / Q000821:virology; D019694:Hepatitis B, Chronic / Q000150:complications / Q000188:drug therapy / Q000503:physiopathology / Q000821:virology; D006801:Humans; D019259:Lamivudine / Q000008:administration & dosage / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D012189:Retrospective Studies; D018894:Reverse Transcriptase Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use*; D013997:Time Factors; D016896:Treatment Outcome
chemical_list: D019380:Anti-HIV Agents; D018894:Reverse Transcriptase Inhibitors; D019259:Lamivudine